Abstract-The purpose of this study was to investigate whether the expression of cellular adhesion molecules (CAMs) is enhanced in individuals with low HDL cholesterol (HDL-C). Plasma levels of soluble vascular cell adhesion molecule-1 (sVCAM-1), intercellular adhesion molecule-1 (sICAM-1), and E-selectin (sE-selectin) were measured in subjects with low (below the 10th percentile for the Italian population), average, or high (above the 90th percentile) HDL-C. Average sICAM-1 and sE-selectin levels were significantly higher in two groups of 65 individuals with low HDL levels, either hyperlipidemic (320.5Ϯ16.0 and 61.4Ϯ3.5 ng/mL) or normolipidemic (309.6Ϯ13.0 and 60.0Ϯ2.7 ng/mL), than in subjects with average HDL levels, either hyperlipidemic (267.0Ϯ10.1 and 50.4Ϯ2.8 ng/mL) or normolipidemic (257.9Ϯ5.4 and 51.1Ϯ2.4 ng/mL), or with high HDL levels (254.8Ϯ10.2 and 52.5Ϯ3.2 ng/mL). No significant difference was found in the plasma sVCAM-1 concentration. HDL-C was inversely correlated with sICAM-1 and sE-selectin in the low-HDL subjects (r 2 ϭ0.087 and 0.035, Pϭ0.0007 and 0.033, respectively), but not in individuals with normal or elevated HDL-C (r 2 ϭ0.012 and 0.006). A fenofibrate-induced increase of HDL-C in 20 low-HDL subjects was associated with a significant reduction of plasma sICAM-1 and sE-selectin concentrations. An increased CAMs expression may be a mechanism by which a low plasma HDL level promotes atherogenesis and causes acute atherothrombotic events.
Caregivers of patients with dementia may experience grief symptoms that are associated with low educational level, high level of burden and anxiety, and high perceived deterioration of their demented relatives' cognitive and functional abilities.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.